$ARNA News S&P 500 back for another crack at major

New Post Public Reply Private Reply Replies (0) Message Board

Oct 21, 2014 at 12:05 PM

$ARNA News

S&P 500 back for another crack at major support 12:21 p.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 12:41 p.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 10:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 10:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 7:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 8:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 3:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy

Orexigen Launches Contrave - Watch For Traction 2:01 p.m. Oct. 20, 2014 - Seeking Alpha
Belviq Sales Dip: What To Watch For Ahead 1:13 p.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
What To Watch For As Orexigen's Launch Approaches 8:05 a.m. Oct. 16, 2014 - Seeking Alpha
Pfizer Setback Could Help Arena 9:44 a.m. Oct. 15, 2014 - Seeking Alpha
Belviq Sales Rise Almost 5% Week Over Week 12:39 p.m. Oct. 10, 2014 - Seeking Alpha
Eisai And Arena Pharmaceuticals Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ (lorcaserin HCl) CIV In Postgraduate Medicine 10:37 a.m. Oct. 10, 2014 - benzinga.com
Orexigen On A Tear - In The Wrong Direction 1:10 a.m. Oct. 7, 2014 - Seeking Alpha
Belviq Sales Flat - Model Your Expectations 6:44 p.m. Oct. 3, 2014 - Seeking Alpha
A Look At Arena's Other Drug 4:37 p.m. Oct. 3, 2014 - Seeking Alpha
Premature Combination Use Of Belviq And Phentermine Is A Risk 9:27 a.m. Sept. 28, 2014 - Seeking Alpha
Arena Pharmaceuticals (ARNA) on NewsMakers in the Biotech Industry Conference Call Transcript 2:22 p.m. Sept. 26, 2014 - Seeking Alpha
Belviq Sales Benefit From Advertising - Up 2.8% 12:16 p.m. Sept. 26, 2014 - Seeking Alpha
Belviq Advertising Sees Major Push - The Equity May See It As Well 5:25 p.m. Sept. 22, 2014 - Seeking Alpha
Belviq Sales Recover From Holiday Dip 5:06 p.m. Sept. 21, 2014 - Seeking Alpha
A Deeper Look At Belviq And Phentermine - Why Investors Need To Model Expectations 12:08 p.m. Sept. 19, 2014 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume 10:04 a.m. Sept. 19, 2014 - TheStreet.com
Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape 9:11 a.m. Sept. 19, 2014 - Zacks.com
It Takes Less Than 15 Minutes To Buy VVUS Shares! 8:51 a.m. Sept. 19, 2014 - Seeking Alpha
Belviq And Phentermine Study Awes Some Investors - Should It? 10:00 a.m. Sept. 17, 2014 - Seeking Alpha

Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 9:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 5:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 11:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 8:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 8:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 9:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4:30 a.m. Aug. 1, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category 8:00 a.m. July 29, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 8:00 a.m. July 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel 8:00 a.m. July 21, 2014 - PR Newswire - PRF
Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line 8:30 a.m. July 16, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office 4:31 p.m. July 15, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV 8:00 a.m. July 10, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare Conference 8:00 a.m. June 13, 2014 - PR Newswire - PRF
Dosing Initiation, Conferences Participation, Trial Results Publication, and Financial Results - Analyst Notes on Arena, Acceleron Pharma, HealthSouth, The Medicines Company and Taro 5:40 a.m. June 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Initiates Phase 1b Clinical Trial of APD334 for Autoimmune Diseases 8:00 a.m. June 3, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grid Hurdles Stalling Industrial Heat's Future Growth

The Grid's the New Ball and Chain Now that we're done fiddling with tech, let's talk grid. The industrial players itching to switch to electric heat have found a new villain: the grid. You'd think with resistance heating, electric boilers, electric arc furnaces, and the whole shebang ready to roll, it’d be a smooth ride. But nope, the bottleneck's the bloodstream...

Critical Questions to Ask When Buying Life Insurance

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Workday's $2.5B Notes Move: What's the Play?

Workday's Strategic Financial Maneuver When a company like Workday starts shaking the trees for $2.5 billion through a senior notes offering, you better believe traders like me are perking up and paying attention. We're talking a registered public offering, no less, which isn't peanuts. With such a substantial move, it's clear Workday (NASDAQ: WDAY) is setting its sights...

Shareholder Watch: VRNS, DSGR, PSNL Under Scrutiny

Navigating Murky Waters: Legal Scrutiny on Shareholder Deals The financial world ain't short on drama these days, and it looks like Varonis Systems, Distribution Solutions Group, and Personalis are right in the thick of it. Each is facing scrutiny over their recent sale transactions that might not be all they’re cracked up to be. Could these deals be shortchanging...

Rising Rates and War in Iran Hit Investor Nerves

An Unsettling Mix for Real Estate Investors The latest RCN Capital Investor Sentiment Survey reveals a shaky real estate landscape, plagued by a mix of geopolitical conflict and central bank policy changes. You know you're in trouble when investor sentiment just crawls back from an all-time low, bouncing barely from an index score of 84 to 89. It's the kind of timid...

Clarivate Taps Global Appetite for AI Research Tools

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

OFN42: Leaders Honored for Community Finance Innovations

A Spotlight on Community Finance Leadership Opportunity Finance Network's annual conference, OFN42, was an event that shined brighter than your typical finance summit. Down in New Orleans, this gathering of community development financial institutions (CDFIs) proved that awards season isn’t just for Hollywood elite. At this meet-up, it’s all about who's not only...

Bybit AI Unveils Personal Finance Customization Spree

What’s New with Bybit AI In a world of cookie-cutter financial platforms, Bybit's latest move feels like a breath of fresh air. Bybit AI isn’t just about rolling out another digital assistant; it's bringing a whole new level to the playing field by letting users create a truly personalized financial journey. It's no wonder they’re backed by a colossal user base of...

Littleton U-Pull-It Kicks off New Era with a Bang

A Fresh Chapter for Littleton U-Pull-It There's nothing quite like the thrill of a new beginning, especially when it promises to shake up the local business scene. Littleton U-Pull-It, under new ownership, seems to be gearing up for exactly that. They're setting the stage with a grand opening event on October 24. When old hands in the business world like me see moves like...

Hanwha Power Gets ABS Green Light for Electric Ship

Breaking New Ground in Maritime Electrification In the world of shipping, Hanwha Power's latest move could be a game-changer. They've landed Approval in Principle from the American Bureau of Shipping (ABS) for a groundbreaking fully electric containership design. Coming straight out of Seoul, this news shook up the maritime crowd in Bergen, Norway, at the recent MHE...